Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000198728 | SCV000253405 | likely benign | Hereditary diffuse gastric adenocarcinoma | 2015-03-27 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000198728 | SCV000488334 | uncertain significance | Hereditary diffuse gastric adenocarcinoma | 2016-03-01 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000996294 | SCV000600949 | likely benign | not provided | 2023-06-03 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000580435 | SCV000684318 | likely benign | Hereditary cancer-predisposing syndrome | 2016-10-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000996294 | SCV001945494 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
European Reference Network on Genetic Tumour Risk Syndromes |
RCV000198728 | SCV003926978 | uncertain significance | Hereditary diffuse gastric adenocarcinoma | 2022-08-01 | criteria provided, single submitter | clinical testing | BS2_Supporting (PMID: 30311375) |
CHEO Genetics Diagnostic Laboratory, |
RCV003491939 | SCV004240417 | likely benign | Breast and/or ovarian cancer | 2022-11-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000580435 | SCV004848949 | uncertain significance | Hereditary cancer-predisposing syndrome | 2015-08-20 | criteria provided, single submitter | clinical testing | The c.*8G>A alteration is located in the 3' untranslated region (3'UTR) of the CDH1 gene. This alteration consists of a deletion of 1 nucleotides after the last coding exon of the CDH1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003927855 | SCV004739489 | likely benign | CDH1-related disorder | 2020-06-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |